In This Section

ASPET - APS Presidential Symposium Series on Inflammation and Oxidative Stress: Inflammation and Drug Disposition

Monday April 06, 2020

8:30 am - 10:00 am

Ballroom 20 A
Co-sponsored by the Division for Behavioral Pharmacology (BEH)
Co-sponsored by the Division for Cancer Pharmacology (DCP)
Co-sponsored by the Division for Cardiovascular Pharmacology (CVP)
Co-sponsored by the Division for Drug Discovery and Development (DDD)
Co-sponsored by the Division for Molecular Pharmacology (MP)
Co-sponsored by the Division for Neuropharmacology (NEU)
Co-sponsored by Division for Toxicology (TOX)

Chair :

Romi Ghose
University of Houston College of Pharmacy

Micheline Piquette-Miller
University of Toronto

ASPET’s President, Dr. Wayne Backes has collaborated with APS’s President, Dr. Meredith Hay, to bring us a workshop and three symposia on inflammation and oxidative stress.

The second symposium in the series will focus on: Inflammation and Drug Disposition.

Impact of Chronic Inflammation and Renal Disease on Drug Metabolism
Thomas Nolin - University of Pittsburgh

Diagnosing NASH through Inflammatory Hepatocyte Hopping Phenoconversion
Nathan Cherrington - University of Arizona Health Sciences

PB-PK Model Approaches to Predict Drug Disposition in Inflammatory Disease
Amin Rostami-Hodjegan - Manchester University

Last Updated: November 8, 2019
Key Dates
March 6

Housing discounts end

March 13

Advance Registration Ends

April 3-4

GPCR Colloquium (separate ticket required)

April 4

ASPET Business Meeting and Awards Presentation

April 4-7

ASPET Annual Meeting at EB 2020

Thank you to our Annual Meeting partners:

University of Kentucky
Icahn School
University of Georgia
University of Minnesota
WSU Pharm-Pharm Sciences Unit
PR & P